Consequences of Pharmaceutical Fraud Settlements: Off-Label Marketing Continues?
Reporter Susan Todd wrote a fine article in the June 6, 2010 Star –Ledger about off-label marketing. “There are very few companies that haven’t had…
Read More »Pharma 101 – Pharmaceutical Fraud
Pharmaceutical Fraud News & Insight form the Qui Tam and False Claims Act Perspective
Contact FormTag Archives: Off label marketing
Johnson & Johnson Subsidiaries to Pay More Than $81 Million to Resolve Allegations of Off-Label Promotion of Topamax
American pharmaceutical manufacturers Ortho-McNeil Pharmaceutical LLC and Ortho-McNeil-Janssen Pharmaceuticals Inc., both subsidiaries of Johnson & Johnson, have agreed to pay more than $81 million to…
Read More »